Physician profile
Benjamin Makamson
NPI 1518960038
$17,605.85
in general payments reported to CMS, 2019-2025
38 companies · $571 in 2025
The $571 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,494 · 2020: $578 · 2021: $1,902 · 2022: $4,713 · 2023: $613 · 2024: $2,735 · 2025: $571.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,403 · Food and Beverage: $1,516.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,403.39 |
| Food and Beverage | $1,515.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $4,165.80 | 2019-2023 | Diamondback Peripheral |
| Siemens Medical Solutions USA, INC. | $4,110.62 | 2019-2024 | Cios Alpha |
| Globus Medical, INC. | $2,403.39 | 2024 | Corbel |
| Organogenesis INC. | $1,814.06 | 2019-2022 | |
| Penumbra, INC. | $1,259.38 | 2021-2025 | Indigo System |
| Medtronic, INC. | $603.39 | 2021-2025 | Endurant Iis, Venaseal |
| Philips North America LLC | $415.73 | 2019-2024 | (Az7) Lasers |
| Bard Peripheral Vascular, INC. | $367.84 | 2019-2024 | Lifestent Solo Vascular Stent |
| Terumo Medical Corporation | $361.00 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $238.78 | 2019-2022 | |
| Stryker Corporation | $220.84 | 2025 | Clottriever Bold Catheter, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $219.49 | 2019-2025 | Enroute Transcarotid Neuroprotection System |
| Cook Medical LLC | $188.98 | 2019-2025 | Icast Covered Stent System, 6mmx22mmx120cm, Zenith Spiral-Z, Zenith |
| Cordis US Corp. | $145.81 | 2022-2023 | Brite Tip Radianz |
| Veryan Medical Incorporated | $144.39 | 2022 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $141.25 | 2019-2024 | Diamondback Peripheral, Absolute Pro |
| Smith+Nephew, INC. | $125.92 | 2019-2021 | |
| W. L. Gore & Associates, INC. | $82.76 | 2019-2024 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Teleflex LLC | $69.98 | 2021-2025 | Manta |
| Angiodynamics, INC. | $56.17 | 2023-2024 | Auryon Laser System 100-120 Vac |
| Vifor Pharma, INC. | $49.91 | 2019-2022 | |
| Tactile Systems Technology INC | $47.09 | 2022-2023 | Flexitouch Plus, Entre Plus |
| Baxter Healthcare | $45.02 | 2020 | |
| Amgen INC. | $42.14 | 2019-2020 | |
| Triad Life Sciences INC. | $36.09 | 2022 | |
| Lemaitre Vascular, INC. | $35.30 | 2024 | Restoreflow, Hydro Lemaitre Valvulotome |
| Biocompatibles, INC. | $25.95 | 2019 | |
| Davol INC. | $25.56 | 2020 | |
| Medtronic Vascular, INC. | $22.22 | 2020 | |
| Daiichi Sankyo INC. | $20.07 | 2019 | |
| Kerecis Limited | $18.90 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Csl Behring | $18.59 | 2019 | |
| Kci USA, INC. | $18.04 | 2021 | |
| Inari Medical, INC. | $17.51 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bioventus LLC | $15.87 | 2022 | |
| Endologix LLC | $11.43 | 2019 | |
| Acera Surgical, INC. | $10.93 | 2019 | |
| Medela LLC | $9.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Makamson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.